Searchable abstracts of presentations at key conferences in endocrinology

ea0081ep242 | Calcium and Bone | ECE2022

Primary vs tertriary hyperparathyroidism in a patient with medullary nefrocalcinosis and chronic renal failure

Shehu Tea , Hoxha Violeta , Ylli Dorina , Cerma Adishah , Ylli Agron

Background: Nephrocalcinosis is characterized by the deposition of calcium products in kidney parenchyma and tubules. It may cause acute or chronic kidney injury or be incidentally detected radiographically in a patient with normal kidney function. Most patients with nephrocalcinosis do not progress to end-stage kidney disease, but with certain underlying conditions, may be associated with progressive kidney dysfunction.Methods: The patient was diagnosed...

ea0090p341 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Prevalence and Impact of Diabetes Mellitus in Adult Tuberculosis Patients;A Cross-Sectional Study

Xhardo Hysenbelli Elona , Hysenbelli Bledar , Ylli Dorina , Smaja Genta

Background: Both diabetes mellitus (DM) and tuberculosis (TB) are major public health problems and among the leading causes of morbidity and mortality worldwide. The TB-DM coexistence is known to complicate TB care, control and prevention. Globally, 10.4 million TB cases exists, of them 10 % are linked to DM. People with DM are at four to five times higher risk of getting infected with tuberculosis and evidence show poor TB treatment outcomes. This study purposed to evaluate t...

ea0035p1019 | Thyroid (non-cancer) | ECE2014

Oral solution of levothyroxine vs tablets in subclinical hypothyroidism: evaluation of outcomes

Pastore Renato , Mentuccia Daniela , Ylli Dorina , Ilaria Giordani , Simona Frontoni

Introduction: Oral levothyroxine (LT4) is the standard treatment for hypothyroidism and serum TSH represents the best marker for assessing the proper LT4 dose. The absorption and bioequivalence of different commercial LT4 preparations might be variable. The aim of this study is to compare the efficacy of levothyroxine oral solution vs tablets.Methods: Fifty-eight patients (six males, 52 females; average age, 46.9±12....

ea0056p416 | Diabetes complications | ECE2018

Comparitive angiographic profile in diabetic and non-diabetic patient (retrospective study)

Dyrmishi Blertina , Olldashi Taulant , Lumi Ema , Puca Entela , YLLI Dorina

Background: Diabetes is one of the risk factor for coronary disease. Patient with diabetes have a increased prevalence and incidence of coronary vessels disease compare with the people without diabetes in the general population.Aim and objectives: To compare the study of angiographic coronary results in the patient with and without diabetes.Materials and methods: 172 pacients; 66 with diabetes and 106 without diabetes was admitted ...

ea0056p801 | Pituitary - Clinical | ECE2018

Gonadotroph pituitary macroadenoma inducing ovarian hyperstimulation syndrome

Dyrmishi Blertina , Olldashi Taulant , Puca Entela , Lumi Ema , Ylli Dorina

Case report: We report a young woman with ovarian hyper stimulation syndrome (OHSS), headache, visual field defect and pituitary macro adenoma. The patient was treated about four years ago as pituitary PRL-secreting adenoma with carbergoline. The evaluation of other hormones FSH, LH and Estradiol values wasn’t done. The patient presented to our hospital with abdominal pain and headaches and amenohrrea. The pregnancy test was negative and pelcic ultrasound demonstrated enl...

ea0075d06 | Diabetes | EYES2021

Factors predisposing to diabetes onset in hospitalised COVID-19 patients

Cerma Adishah , Muja Ardita , Haxhiraj Adela , Ylli Dorina

Background: The presence of diabetes and the degree of hyperglycemia is considered an independent factor in the clinical severity of COVID-19 infection, impacting the duration of hospital stay and other related medical conditions.Objective: To identify the correlation between the insulin needs in COVID-19 patients and hospital stay and other related medical conditions. To identify the factors that would contribute to diabetes onset during COVID-19 infect...

ea0092ps1-02-06 | Graves’ Disease | ETA2023

The role of selenium supplement in graves disease - a case report

Haxhiraj Adela , Poshi Klodiana , Hoxha Violeta , Kermaj Marjeta , Ylli Dorina

Introduction: Selenium is a mineral that plays a key role in the intracellular reactions of the thyroid. Some selenium-based proteins have a protective antioxidant function in thyrocytes. Likewise, Selenium is incorporated into deiodinases, helping in the synthesis of thyroid hormones. Through its antioxidant and anti inflammatory properties, selenium affects the development of autoimmune thyroid diseases, such as Graves Disease. Supplementation with selenium is often prescrib...

ea0099p45 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

The impact of diabetes mellitus on morbidity and mortality in patients with covid-19 pneumonia. retrospective study

Xhardo Hysenbelli Elona , Hysenbelli Bledar , Telo Sofiela , Ylli Dorina

Background: The relationship between diabetes and COVID-19 is known to be bidirectional. Diabetes Mellitus (DM) and hyperglycemia are important risk factors for poor outcomes in hospitalized patients with coronavirus disease 2019 (COVID-19) pneumonia.Objective: This study aimed to evaluate the impact of glycemic control pre- and after admission, on outcomes of hospitalised patients with COVID-19 pneumonia.Methods: A total of 400 ho...

ea0099ep1215 | Adrenal and Cardiovascular Endocrinology | ECE2024

Addison’s disease presented as a persistent hyperkaliemia in a patient with diabetic ketosis and autoimmune polyendocrine syndrome type 2 (APS-2). a case report and review of literature

Kermaj Marjeta , Ylli Dorina , Hoxha Violeta , Poshi Klodiana , Ylli Agron

Introduction: APS-2 is the most common autoimmune polyendocrine syndrome. It is characterized by the presence of various endocrine-related diseases, such as autoimmune thyroid disease, type 1 diabetes mellitus, Addison’s disease, primary hypogonadism, and, in rarer cases, hypoparathyroidism or hypopituitarism.Case report: Our patient is a 38-year-old female with a medical history of type 1 diabetes mellitus (DMT1) for 13 years, Hashimoto’s thyr...

ea0099ep539 | Thyroid | ECE2024

Hyperthyroidism induced by metastatic distant thyroid carcinoma

Ylli Dorina , Hoxha Violeta , Poshi Klodiana , Kermaj Marjeta , Ylli Agron

Background: We present a rare case of a 64-year-old patient diagnosed with longstanding untreated Graves’ disease and co-occurrence of metastatic thyroid cancer. Very few cases are reported in literature where the thyrotoxicosis in due to the distant metastasis and optimal treatment remains challenging.Case Presentation: The patient came to the endocrine unit for thyrotoxicosis treatment. He was diagnosed with Graves’ disease and following trea...